The identification and isolation of individuals with COVID-19 can help to flatten the epidemic curve and win us time to wait for the vaccine development and production and antiviral drug therapies (this is the Nature Nano editorial for the April issue which will be published in the next few days).
Having early and rapid access to research findings accelerates the pace of science and is paramount for advancing discovery. As publishers we are ideally placed to help facilitate this and here at Springer Nature making great research available as quickly as possible is a central part of our commitment to the research community.
Meet our authors from RIKEN Bioresource Research Center, Meijo University, and the National Institute of Advanced Industrial Science and Technology in Japan to learn about their fascinating invention for improving pluripotent stem cell culturing.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activites described below. To learn more about how these trackers help us
Register to Nature Portfolio Bioengineering Community
The Nature Portfolio Bioengineering Community is a community blog for readers and authors of Nature Research journals, including Nature Biomedical Engineering, Nature Biotechnology, Nature Communications, Nature Medicine, and others. Become a member, and contribute with research news and stories.